Over 1.8 million nonprofits and charities for donors, volunteers and funders

Claim This Nonprofit

More Info

Add to Favorites

Share this Nonprofit

Donate

Volunteering Oportunities

Nonprofit Overview

Causes: Government & Public Administration, Health, Medical Research, Mental Health, Mental Health Treatment

Mission: Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS furthers its mission by: -Developing psychedelics and marijuana into prescription medicines -Training therapists and working to establish a network of treatment centers -Supporting scientific research into spirituality, creativity, and neuroscience -Educating the public honestly about the risks and benefits of psychedelics and marijuana MAPS envisions a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.

Results: MAPS has completed two Phase 2 FDA studies using MDMA-assisted psychotherapy to treat PTSD, and is in the process of four other similar studies. MAPS also has a study looking at LSD-assisted psychotherapy for treating end-of-life anxiety, an outcome study of the benefits of ibogaine for opiate dependence, and a protocol to investigate medical marijuana to relieve symptoms of PTSD.

Target demographics: Any person whose life may be aided by the transformative nature of psychedelic psychotherapy

Geographic areas served: Worldwide

Programs: Maps' primary focus is research into mdma-assisted psychotherapy ($1,094,575), especially phase 2 research into mdma-assisted psychotherapy in subjects with chronic, treatment-resistant ptsd. In this fiscal year, maps treated the 18th subject in our charleston, south carolina mdma/ptsd study in 24 veterans, firefighters and police officers. An 8th subject was treated in our study in boulder, colorado for people suffering from ptsd from any source, a fourth subject was treated in our mdma/ptsd study in beer yaakov, israel, and an irb approved the amendments for our mdma/ptsd study in vancouver, canada. A 7th therapist participated in our mdma-assisted psychotherapy therapist training study. In addition to our core clinical research, this fiscal year we began planning a series of studies in collaboration with researchers who work with the u. S. Department of veterans affairs' national center for ptsd. We'll be exploring the use of mdma along with more traditional psychotherapeutic methods for treating ptsd including cognitive-behavioral conjoint therapy, cognitive processing therapy, and prolonged exposure therapy. We also began our study looking at the safety and efficacy of using mdma-assisted therapy for anxiety in adults on the autism spectrum and began preparations for a study of mdma-assisted psychotherapy for end-of-life anxiety. These studies will grow significantly in the coming year. Mdma-study related program expenses include costs of video data storage and streaming systems development, budgeting, contracting, and meetings; the costs of developing the treatment manual; training therapists; blinded therapist adherence training; and costs of reviewing and documenting all published mdma literature. There are also mdma-study related supervision of therapists, presentation of our data at professional conferences, and costs to manage the mdma purchased early in our work and to secure the drug for phase 3 trials expected to begin in 2016. Clinical research general costs cover the development of the infrastructure needed for our mdma clinical trials, including work with communications and fundraising departments, staff professional development and conferences, and video streaming and statistical software. Most of the clinical research expenses are personnel, including personnel at each study site: principal investigators, co-investigators, independent raters, overnight physicians, attendant, and study coordinators, as well as maps' internal staff: the clinical director, research associates, information specials, data coordinators and statistical consultants. Ibogaine research expenses were dedicated to completing our studies in mexico ($3,816), and new zealand ($6,329). Lsd research expenses ($12,185) were primarily used for the march 2014 publication of our lsd end-of-life anxiety article in the journal of nervous and mental disease. Marijuana research ($14,905) covered the costs of developing the protocol for a pilot study in which marijuana will be tested to manage symptoms in 76 veterans with chronic, treatment-resistant ptsd, and our efforts to end the public health service (phs) review and the national institute of drug abuse (nida) monopoly of the sale of marijuana for clinical research.

education expenses include harm reduction, events, publications and communications programs. Our zendo project provides a supportive space for people undergoing difficult psychedelic experiences in order to help turn those experiences into opportunities for learning and personal growth, and to reduce the number of drug-related psychiatric hospitalizations and arrests. Services were provided at five major events in fiscal year 2014: burning man (black rock city, nv), envision (costa rica), afrikaburn (south africa), bicycle day (san francisco, ca), and lightning in a bottle (bradley, ca). In order to share recent findings and to inspire existing and new support, maps produced events on psychedelic and marijuana research in colorado, vancouver and santa cruz; and attended more than 17 events that others produced, providing speakers, exhibits, sales of books and maps bulletins, and free distribution of clinical protocols and articles from peer-reviewed journals. Communications included publishing three maps bulletins, and 12 email newsletters, maintaining maps. Org, mdmaptsd. Org, mapscanada. Org, psychedelicscience. Org, and launching mdma-autism. Org. Maps produced "manifesting minds," with north atlantic books, reprinted albert hofmann's "lsd: my problem child," and began work with stanislav grof on his new book, "the visionary world of h. R. Giger. " in spring 2014, maps offered its first webinar, "psychedelic science," in collaboration with evolver learning labs. Maps saw significant growth in coverage of its work in social, online, and traditional media. Maps. Org had 511,449 unique visits and 1,809,246 page views. Facebook likes more than doubled to 89,282. Twitter followers increased 140%, to 17,099. Youtube subscriptions increased 256% to 5,313. Maps received 344 unique media mentions from online and print publications with significant reach. Media outlets include the los angeles times, the new york times, the san francisco chronicle, reason, scientific american, cnn, usa today, msnbc, time, associated press, fox news, forbes, nbc news, playboy, santa cruz sentinel, tricycle, business insider, npr, vice, and southern california public radio (kpcc).

this year, maps operationalized its long-running fiscal sponsorship program, clarifying and updating contracts, process, and structure. This program supports projects that are in alignment with maps mission and vision by offering donors a way to give to a 501(c) 3 nonprofit organization. Maps monitors the project budget, takes a small fee, and sends the donor a receipt for their contribution.

Community Stories

111 Stories from Volunteers, Donors & Supporters

1

Volunteer

Rating: 5

MAPS, is a leading researcher & advocate for Psychedelics for healing PTSD, depression, anxiety disorders, for Spiritual growth & self-discovery.
* Zendo, MAPS Psychedelic Harm Reduction Organization works at festivals training 100s of people a year, assisting many more.
* MAPS has completed Phase 1 & 2 FDA/DEA approved trials for MDMA “Combined Therapy” working at John Hopkins with Vets w/PTSD w/great success & heads into phase 3 trials for approval 2017...Psilocybin-for End of Life issues... They've made a considerable contribution to Psychedelic education, research & medicine,,, Freedom of Consciousness...

1

Volunteer

Rating: 5

I support MAPS' work because I am in favour of learning how we as a species can make happiness more accessible. The results of pushing to develop more psychedelic medicines have repeatedly confirmed the validity of this caus and we need a great variety of tools at our disposal.

Volunteer

Rating: 5

Thanks to the brave work of MAPS, research into the effects of psychedelic drugs on consciousness have become a growing field of study in American academia.
The recent studies and their promising results are leading to a wider interest in psychedelic substances. My work with some of those substances have paved my way out of addiction and changed my life for the better in ways I didn't think possible.

Volunteer

Rating: 5

I have finally got some relief. Knowing MAPS work in helping the PTSD problem in our military. I feel that we have made a leap in to our future help with PTSD. And other related mental health problems. Thank You MAPS

1 Alon E.

Volunteer

Rating: 4

MAPS-multidisciplinary association for psychedelic studies
They general theory behind this- the combination of PROFESSIONALLY SUPERVISED cognitive therapy, with certain substances (MDMA for post trauma, lsd, dmt, psilocybin, ibogaine, mescaline, and ketamine for other purposes such as addictions) has PROVEN to highly effective in enough cases to warrant further research.
1) Support what works. The number of success stories speak for themselves

2) The original stigma- that psychedelics cannot be used medicinally due to their psychological effects- has been formally discredited.

As for abuse, OxyContin, Vicodin, Xanex, Percocet, and even COUGH SYRUP are abused. The potential for something to be abused is not an argument against it- look at the second amendment; it's merely an argument against irresponsibility.

Psychedelics simply ought to be regulated and administered with appropriately stringent laws, just like any other potent pharmacological products that are already on the shelves.

Volunteer

Rating: 3

Having experienced mescaline as a young and reckless adolescent just for some colourful kicks, I soon discovered that there was an intrinsic meaning present and an elder fortunately showed me the respect and reverence that these pants deserved. From here I was shown their true potential to reveal our true place as humans in the cosmic web of life, our significance and our misplaced self-importance. These latter events left me with profoundly life-altering and personally trans-formative experiences that I will never forget and guided my life in directions that seemed to be fortuitous becoming an integral part of who I am now some 25 years later. That organizations like MAPS exist vindicates the validity of these experiences for me as not just 'crazy trips' but as the spiritual and deeply insightful phenomenon that they are. It is clear that the (historically recent) current drug enforcement and prohibition paradigm has continually been shown as ineffective, counter-productive and destructive and a war which unfortunately Psychedelic/entheogenic substances have been caught in. Plant substances hold enormous value for the human condition and their millennial old presence in ritual/ceremonial religious contexts across the globe vindicates the validity of studying and examining the effects on these substances with academic rigour. As my own experiences so profoundly changed my inner being, when I came to academics late in life, I found within my Cultural Studies major that the vicissitudes of everyday life, our inculcation and socialization into negative patterns of consumption and behaviour are so entirely capable of being reconfigured by psychedelics. Not only for the momentary stripping away of the ego and the profound connection and visualization of all living networks from the micro to the macro cosmic level, but for the deep realization that we are all connected and more similar than different. I am hoping to go on and examine an apparent revival in legitimate psychedelic-entheoegenic cultures and how they affect peoples articulations of spirituality in the spirit of James William's 'Varieties of Religious Experience'....for this I am endlessly grateful to MAPS for providing scientific literary resources and ongoing academic investigation through a range of disciplines. This may well be one of the most important techniques and fields of study in the 21st century if we are to progress from the ego-based destructive drive that is turning humanity against it self and its environment and move toward a new era of cooperation, awareness and sustainability through legitimate scientific discourse

Volunteer

Rating: 5

one of the most upcomming and important organizations. There is so much treatment, public health, and general reseach potential here which is not nearly enough explored.

Volunteer

Rating: 5

Psychadelics help evolve mankind in his endless journey for enlightenment. Psychadelics have an extremely beneficial effect on any person that thinks they are ready to take in what their subconciouse wants to tell them. Please continue the research on psychadelics so that we can get a better scientific understanding of them.

Jokuri

Volunteer

Rating: 5

I have worked with MAPS as a volunteer at their last conference and everything was organized really professionally. I can't think anything negative to say about how MAPS functions. They are working to help relieve sufferings of millions and to further the evolution of mankind with the help of psychedelic substances - medicines and tools.

Josef K.

Volunteer

Rating: 5

I volunteered as a clinical intern for the academic year of 2012-2013 and it was one of the best experiences of my life! Everyone involved at MAPS is so amazing and I want to come back to work for them someday.